BSE Announcement

ADC India Communications will hold a meeting of the Board of Directors of the Company on 12 August 2026.

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Oseltamivir Phosphate for Oral Suspension, 6 mg/mL.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Tamiflu Oral Suspension, 6 mg/mL, of Hoffmann-La Roche, Inc.

Oseltamivir Phosphate is an influenza neuraminidase inhibitor (NAI) indicated for: i) treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours, and ii) Prophylaxis of influenza A and B in patients 1 year and older.

Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, have an estimated market size of US$ 27 million for twelve months ending March 2026 according to IQVIA.

Amal will hold a meeting of the Board of Directors of the Company on 17 July 2026.

Asian Hotels (East) will hold a meeting of the Board of Directors of the Company on 9 July 2026.

Atul will hold a meeting of the Board of Directors of the Company on 24 July 2026.

Aye Finance has allotted 14,000 non convertible debentures having face value of Rs 1 lakh each aggregating to Rs 140 crore to Nederlandse Financierings Maatschappij voor Ontwikkelingslanden N.V. (FMO), on private placement basis.

Bagmane Prime Office REIT announced that the 1st Annual General Meeting(AGM) of the company will be held on 20 July 2026.

BEML has received an additional export Order valued at approximately USD 5.35 Million from the Middle East region for the supply of heavy Earth Moving Equipment for Infrastructure development applications.

Bhagyanagar India will hold a meeting of the Board of Directors of the Company on 30 June 2026.

Bharat Bijlee will hold a meeting of the Board of Directors of the Company on 4 August 2026.